Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,069 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
6-Month Clinical and Angiographic Outcomes of a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold: The FANTOM II Study.
Abizaid A, Carrié D, Frey N, Lutz M, Weber-Albers J, Dudek D, Chevalier B, Weng SC, Costa RA, Anderson J, Stone GW; FANTOM II Clinical Investigators. Abizaid A, et al. Among authors: dudek d. JACC Cardiovasc Interv. 2017 Sep 25;10(18):1832-1838. doi: 10.1016/j.jcin.2017.07.033. JACC Cardiovasc Interv. 2017. PMID: 28935075 Free article.
Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters a feasibility study.
Bruining N, de Winter S, Roelandt JR, Regar E, Heller I, van Domburg RT, Hamers R, Onuma Y, Dudek D, Webster MW, Thuesen L, Ormiston JA, Cheong WF, Miquel-Hebert K, Veldhof S, Serruys PW. Bruining N, et al. Among authors: dudek d. JACC Cardiovasc Interv. 2010 Apr;3(4):449-56. doi: 10.1016/j.jcin.2010.02.004. JACC Cardiovasc Interv. 2010. PMID: 20398874 Free article. Clinical Trial.
Impact of bivalirudin therapy in high-risk patients with acute myocardial infarction: 1-year results from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial.
Parodi G, Antoniucci D, Nikolsky E, Witzenbichler B, Guagliumi G, Peruga JZ, Stuckey T, Dudek D, Kornowski R, Hartmann F, Lansky AJ, Mehran R, Stone GW. Parodi G, et al. Among authors: dudek d. JACC Cardiovasc Interv. 2010 Aug;3(8):796-802. doi: 10.1016/j.jcin.2010.05.009. JACC Cardiovasc Interv. 2010. PMID: 20723849 Free article. Clinical Trial.
Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction trial.
Palmerini T, Mehran R, Dangas G, Nikolsky E, Witzenbichler B, Guagliumi G, Dudek D, Genereux P, Caixeta A, Rabbani L, Weisz G, Parise H, Fahy M, Xu K, Brodie B, Lansky A, Stone GW. Palmerini T, et al. Among authors: dudek d. Circulation. 2011 Jun 21;123(24):2829-37, 7 p following 2837. doi: 10.1161/CIRCULATIONAHA.110.985564. Epub 2011 May 31. Circulation. 2011. PMID: 21632496 Clinical Trial.
Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial).
Singh HS, Dangas GD, Guagliumi G, Yu J, Witzenbichler B, Kornowski R, Grines C, Gersh B, Dudek D, Mehran R, Stone GW. Singh HS, et al. Among authors: dudek d. Am J Cardiol. 2012 Oct 1;110(7):940-7. doi: 10.1016/j.amjcard.2012.05.026. Epub 2012 Jun 28. Am J Cardiol. 2012. PMID: 22748356 Clinical Trial.
PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.
Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Savonitto S, Torremante P, Vrints C, Schneider S, Desch S, Zeymer U; CULPRIT-SHOCK Investigators. Thiele H, et al. N Engl J Med. 2017 Dec 21;377(25):2419-2432. doi: 10.1056/NEJMoa1710261. Epub 2017 Oct 30. N Engl J Med. 2017. PMID: 29083953 Free article. Clinical Trial.
Classification of coronary artery bifurcation lesions and treatments: time for a consensus!
Louvard Y, Thomas M, Dzavik V, Hildick-Smith D, Galassi AR, Pan M, Burzotta F, Zelizko M, Dudek D, Ludman P, Sheiban I, Lassen JF, Darremont O, Kastrati A, Ludwig J, Iakovou I, Brunel P, Lansky A, Meerkin D, Legrand V, Medina A, Lefèvre T. Louvard Y, et al. Among authors: dudek d. Catheter Cardiovasc Interv. 2008 Feb 1;71(2):175-83. doi: 10.1002/ccd.21314. Catheter Cardiovasc Interv. 2008. PMID: 17985377 Free article.
Safety and efficacy of the NovaCross microcatheter in facilitating crossing of chronic total occlusion coronary lesions: a multicenter, single-arm clinical trial.
Walsh SJ, Dudek D, Bryniarski L, Nicholson W, Karmpaliotis D, Uretsky B, McEntegart M, Assali A, Knaapen P, Kornowski R, Spratt JC, Goodwin M, Hanratty CG. Walsh SJ, et al. Among authors: dudek d. Coron Artery Dis. 2020 Nov;31(7):573-577. doi: 10.1097/MCA.0000000000000947. Coron Artery Dis. 2020. PMID: 32868660 Clinical Trial.
1,069 results